West Pharmaceutical Services, Inc. (WST)

Growth

Revenue 5Y13.23%
Revenue 3Y18.14%
EPS 5Y35.52%
EPS 3Y47.34%
Dividend 5Y7.20%
Dividend 3Y6.67%

Capital Efficiency

ROIC27.56%
ROE26.39%
ROA19.01%
ROTA19.12%

Capital Structure

Market Cap19.79B
EV19.36B
Cash729M
Current Ratio3.80
Debt/Equity0.26
Net Debt/EBITDA-0.49
Show More

Income Statement

Select a metric from the list below to chart it

Dec '85
Dec '92
Dec '99
Dec '06
Dec '13
Dec '20
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
1,368.4
1,421.4
1,399.8
1,509.1
1,599.1
1,717.4
1,839.9
2,146.9
2,831.6
2,909.0
Revenue % Chg.
8.1%
3.9%
-1.5%
7.8%
6.0%
7.4%
7.1%
16.7%
31.9%
8.5%
Cost of Revenue
933.7
973.6
944.0
1,008.0
1,086.5
1,172.0
1,234.2
1,379.1
1,655.8
1,734.3
Cost of Revenue % Chg.
6.3%
4.3%
-3.0%
6.8%
7.8%
7.9%
5.3%
11.7%
20.1%
8.8%
Gross Profit
434.7
447.8
455.8
501.1
512.6
545.4
605.7
767.8
1,175.8
1,174.7
Gross Profit % Chg.
12.1%
3.0%
1.8%
9.9%
2.3%
6.4%
11.1%
26.8%
53.1%
8.1%
Gross Profit Margin
31.8%
31.5%
32.6%
33.2%
32.1%
31.8%
32.9%
35.8%
41.5%
40.4%
Gross Profit Margin % Chg.
3.8%
-0.8%
3.4%
2.0%
-3.5%
-0.9%
3.7%
8.6%
16.1%
-0.3%
R&D Expenses
37.9
38.5
34.1
36.8
39.1
40.3
38.9
46.9
52.8
56.3
R&D Expenses % Chg.
14.2%
1.6%
-11.4%
7.9%
6.3%
3.1%
-3.5%
20.6%
12.6%
8.3%
Selling, General, & Admin Expenses
234.9
228.7
243.9
237.7
242.6
262.9
272.7
302.0
362.8
329.2
Selling, General, & Admin Expenses % Chg.
7.7%
-2.6%
6.6%
-2.5%
2.1%
8.4%
3.7%
10.7%
20.1%
-3.5%
Other Expenses
-
-1.6
-1.5
-1.6
-6.7
-5.7
-10.5
-
-
-
Other Expenses % Chg.
-
-
6.3%
6.7%
318.8%
14.9%
84.2%
-
-
-
Operating Income
162.4
182.0
128.6
196.8
228.9
240.3
296.6
406.9
752.3
788.3
Operating Income % Chg.
20.2%
12.1%
-29.3%
53.0%
16.3%
5.0%
23.4%
37.2%
84.9%
15.2%
Operating Income Margin
11.9%
12.8%
9.2%
13.0%
14.3%
14.0%
16.1%
19.0%
26.6%
27.1%
Operating Income Margin % Chg.
11.2%
7.9%
-28.3%
41.9%
9.8%
-2.3%
15.2%
17.6%
40.2%
6.2%
Total Other Income/Expenses Net
-15.3
-13.0
-12.5
-7.0
-6.5
0.4
-4.8
-5.6
-3.4
-55.2
Total Other Income/Expenses Net % Chg.
42.3%
15.0%
3.8%
44.0%
7.1%
-
-
16.7%
39.3%
2300.0%
Income Before Tax
147.1
169.0
116.1
189.8
222.4
240.7
291.8
401.3
748.9
733.1
Income Before Tax % Chg.
35.5%
14.9%
-31.3%
63.5%
17.2%
8.2%
21.2%
37.5%
86.6%
7.5%
Income Before Tax Margin
10.7%
11.9%
8.3%
12.6%
13.9%
14.0%
15.9%
18.7%
26.4%
25.2%
Income Before Tax Margin % Chg.
25.4%
10.6%
-30.2%
51.6%
10.6%
0.8%
13.2%
17.9%
41.5%
-0.9%
Income Tax Expense
40.2
47.2
26.3
54.4
80.9
41.4
59.0
72.5
107.2
120.0
Income Tax Expense % Chg.
22.9%
17.4%
-44.3%
106.8%
48.7%
-48.8%
42.5%
22.9%
47.9%
28.5%
Net Income
112.3
127.1
95.6
143.6
150.7
206.9
241.7
346.2
661.8
630.6
Net Income % Chg.
39.2%
13.2%
-24.8%
50.2%
4.9%
37.3%
16.8%
43.2%
91.2%
3.0%
Net Income Margin
8.2%
8.9%
6.8%
9.5%
9.4%
12.0%
13.1%
16.1%
23.4%
21.7%
Net Income Margin % Chg.
28.8%
9.0%
-23.6%
39.3%
-1.0%
27.8%
9.0%
22.8%
44.9%
-5.1%
Weighted Avg. Shares Out
69.6
70.9
72.0
73.3
73.9
73.9
74.0
73.9
73.9
74.5
Weighted Avg. Shares Out % Chg.
2.4%
1.9%
1.6%
1.8%
0.8%
-
0.1%
-0.1%
-
0.6%
EPS
1.6
1.8
1.3
2.0
2.0
2.8
3.3
4.7
9.0
8.5
EPS % Chg.
35.9%
11.2%
-25.7%
47.4%
4.1%
37.3%
16.8%
43.1%
91.5%
2.3%
Weighted Avg. Shares Out Dil
71.4
72.8
73.8
75.0
75.8
75.4
75.4
75.8
75.8
76.1
Weighted Avg. Shares Out Dil % Chg.
-0.6%
2.0%
1.4%
1.6%
1.1%
-0.5%
-
0.5%
-
0.2%
EPS Diluted
1.6
1.8
1.3
1.9
2.0
2.7
3.2
4.6
8.7
8.3
EPS Diluted % Chg.
36.5%
11.5%
-25.7%
46.9%
4.2%
37.7%
17.2%
42.4%
91.0%
2.6%
Interest Income
1.9
3.5
1.6
1.1
1.3
2.1
3.8
1.4
1.0
2.5
Interest Income % Chg.
5.6%
84.2%
-54.3%
-31.3%
18.2%
61.5%
81.0%
-63.2%
-28.6%
177.8%
Interest Expense
17.0
16.5
14.1
8.1
7.8
8.4
8.5
8.2
8.2
9.2
Interest Expense % Chg.
1.8%
-2.9%
-14.5%
-42.6%
-3.7%
7.7%
1.2%
-3.5%
-
19.5%
EBIT
132.0
156.0
103.6
182.8
215.9
234.4
287.1
394.5
741.7
726.4
EBIT % Chg.
40.9%
18.2%
-33.6%
76.4%
18.1%
8.6%
22.5%
37.4%
88.0%
7.6%
EBIT Margin
9.6%
11.0%
7.4%
12.1%
13.5%
13.6%
15.6%
18.4%
26.2%
25.0%
EBIT Margin % Chg.
30.4%
13.8%
-32.6%
63.7%
11.5%
1.1%
14.3%
17.8%
42.5%
-0.9%
Depreciation & Amortization
85.2
90.0
89.9
90.7
96.7
104.4
103.4
109.1
122.3
123.9
Depreciation & Amortization % Chg.
10.8%
5.6%
-0.1%
0.9%
6.6%
8.0%
-1.0%
5.5%
12.1%
6.4%
EBITDA
217.2
246.0
193.5
273.5
312.6
338.8
390.5
503.6
864.0
850.3
EBITDA % Chg.
27.3%
13.3%
-21.3%
41.3%
14.3%
8.4%
15.3%
29.0%
71.6%
7.4%
EBITDA Margin
15.9%
17.3%
13.8%
18.1%
19.5%
19.7%
21.2%
23.5%
30.5%
29.2%
EBITDA Margin % Chg.
17.8%
9.0%
-20.1%
31.1%
7.9%
0.9%
7.6%
10.5%
30.1%
-1.0%